As we conclude our years-long exploration of pricing in healthcare, the central theme of our 2023 Business of Health Conference, we are pleased to present our final output on the topic: a whitepaper that delves into pharmaceutical pricing and innovation. Produced following a Chatham House Rules conference earlier this year, the whitepaper aims to provide general audiences with insights into the complexities of pharmaceutical innovation and pricing, as well as the current realities within our healthcare system related to this critical issue.

A February cyberattack targeting Change Healthcare resulted in the most extensive healthcare data breach to date, raising questions about industrywide risk management and regulation.

As demand grows for the drugs that aid weight loss and reduce cardiovascular risks, the pressing question remains: 'Who will cover the costs?' Here’s a brief overview of the current discourse on this issue.